The long‐term efficacy of combining nucleos(t)ide analog and low‐dose hepatitis B immunoglobulin on post‐transplant hepatitis B virus recurrence

Abstract

The combination of ETV or TDF and low-dose HBIG achieved a more favorable prophylaxis against HBV recurrence after LT. The presence of HCC prior to LT was associated with post-transplant HBV recurrence.